Ascelia Pharma: Time for take-off
Research Update
2024-05-20
08:19
Ascelia’s Q1 result was minor compared to the recent SPARKLE success. Ascelia is preparing for submission by mid-2025, and Ascelia’s cost base was contained. Our Base Case is SEK 17 (Bull SEK 45 and Bear SEK 6).
JU
Johan Unnerus
Disclosures and disclaimers